Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Ensuring fast payments from clients can improve your financial stability. Discover key strategies to achieve this.
15,939 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A small nuclear energy company under $4B could ride a global revival in clean power. Learn how to evaluate this nucle...
A growing share of Americans are skipping books, a trend that billionaires say they avoided as well. Experts warn the...
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
More than 200 economists, including 16 Nobel laureates, sign a call admitting they lack clarity on AI's economic effe...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
Kick off your week with a concise, practical set of market notes. This Tuesday reads guide blends data, strategy, and...
Acting Attorney General faced sharp questions at a Senate confirmation hearing about the fate of the controversial fu...
Base founder Jesse Pollak is stepping back from day-to-day leadership after acknowledging a failed social strategy. T...
Karooooo stock jumped today after a solid earnings report that topped expectations. This article breaks down the numb...
August earnings looms for Nvidia and AMD. This guide helps you understand potential market moves and how to position ...
SpaceX investor hype meets timeless Buffett wisdom. These Warren Buffett quotes must guide your SpaceX stock decision...